Skip to main content
. 2017 Jul 27;28(10):2503–2510. doi: 10.1093/annonc/mdx340

Figure 1.

Figure 1.

Prognostic value of MRD in post-ASCT BM samples for patients with multiple myeloma according to MRD level as determined by deep sequencing (threshold: 10−6). (A) PFS for all patients, (B) OS for all patients, and (C) PFS for patients achieving conventional CR from ASCT. (D) PFS for all patients, (E) OS for all patients, and (F) PFS for patients achieving conventional CR from BM MRD assessment.